With the news of certain American Hedge Funds taking position in the stock with reasonings like , " Syngenta in Switzerland is a big company trading at PE of 20-21. In India, one can buy at the component at PE of 8-9. If one sees the growth prospectus in India, there is a lot of potential." there seems to be lot of genuine buying interest coming into the counter.
Also on the valuation based on peer performance basis shown below we beleive that SYNGENTA deserves a re-rating.
Company Sales (rs cr.) PAT (rs cr.) Market Cap (rs cr.)
Novartis 525.30 107.89 1,518.26
Monsanto 378.90 76.78 1,357.84
Syngenta 767.13 80.22 977.99
Bayer Cropsc 679.05 37.15 581.42
Monday, August 21, 2006
Subscribe to:
Posts (Atom)